Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial
Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page
- Check6 days agoChange DetectedOnly a minor revision label was updated: Revision: v3.3.2 appears where v3.3.1 was previously listed. This does not alter study details, eligibility criteria, outcomes, or any functional elements of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe Publications section description now states that publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check21 days agoChange Detected- The government funding/operating status notice in the page footer has been removed. - The page now presents study details without that disclaimer.SummaryDifference0.4%

- Check35 days agoChange DetectedNo additions or deletions detected; the page content and study details appear unchanged from the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check64 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 version; old v3.1.0 reference removed.SummaryDifference4%

- Check71 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.